BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2027300)

  • 1. Effect of hyperthermia on both primary proliferation and self-renewal of human leukemic progenitor cells in vitro: its application to in vitro purging.
    Moriyama Y; Nikkuni K; Saito H; Aoki A; Kishi K; Takahashi M; Shibata A
    Leukemia; 1991 Apr; 5(4):332-5. PubMed ID: 2027300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging.
    Moriyama Y; Goto T; Nikkuni K; Aoki A; Furukawa T; Narita M; Koyama S; Kishi K; Takahashi M; Shibata A
    Bone Marrow Transplant; 1991 Oct; 8(4):301-5. PubMed ID: 1756327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic purging in vitro of murine leukemia cells (MK-8057): surviving fractions of normal and leukemic stem cells and the long-term survival of mice injected with the post-hyperthermic leukemia cells.
    Iwasawa T; Hirabayashi Y; Kubota N; Inoue T; Kakehi M; Matsui K
    Exp Hematol; 1991 Jun; 19(5):332-7. PubMed ID: 2026185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J; Fehér I; Kovács P
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro sensitivity of human hematopoietic progenitor cells to hyperthermia: critical temperature for cells to survive and its application to in vitro purging.
    Moriyama Y; Nikkuni K; Saito H; Aoki A; Furukawa T; Imanari A; Narita M; Kishi K; Takahashi M; Shibata A
    Bone Marrow Transplant; 1990 Oct; 6(4):243-6. PubMed ID: 2085698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia.
    Murphy PB; Richman CM
    Exp Hematol; 1989 Dec; 17(11):1105-9. PubMed ID: 2583254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in the cultures in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):495-500. PubMed ID: 1668709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
    Grant S; Pettit GR; Howe C; McCrady C
    Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression.
    Wierenga PK; Brenner MK; Konings AW
    Bone Marrow Transplant; 1998 Jan; 21(1):73-8. PubMed ID: 9486498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
    Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
    Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
    Motoji T; Takanashi M; Fuchinoue M; Masuda M; Oshimi K; Mizoguchi H
    Exp Hematol; 1989 Jan; 17(1):56-60. PubMed ID: 2783249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melphalan against self-renewal capacity of leukemic progenitors in acute myeloblastic leukemia.
    Demur C; Chiron M; Saivin S; Attal M; Dastugue N; Bousquet C; Galinier JL; Colombies P; Laurent G
    Leukemia; 1992 Mar; 6(3):204-8. PubMed ID: 1564957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J; Fehér I
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
    Allieri MA; Lopez M; Douáy L; Mary JY; NGuyen L; Gorin NC
    Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of hyperthermia to the treatment of human acute leukemia: purging human leukemic progenitor cells by heat.
    Moriyama Y; Narita M; Sato K; Urushiyama M; Koyama S; Hirosawa H; Kishi K; Takahashi M; Takai K; Shibata A
    Blood; 1986 Mar; 67(3):802-4. PubMed ID: 3511987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in heat sensitivity between normal and acute myeloid leukemic stem cells: feasibility of hyperthermic purging of leukemic cells from autologous stem cell grafts.
    Wierenga PK; Setroikromo R; Kamps G; Kampinga HH; Vellenga E
    Exp Hematol; 2003 May; 31(5):421-7. PubMed ID: 12763141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.